These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24987117)

  • 1. The Good, the Bad, and the Ugly: in search of gold standards for assessing functional genetic screen quality.
    Evers B; Bernards R; Beijersbergen RL
    Mol Syst Biol; 2014 Jul; 10(7):738. PubMed ID: 24987117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring error rates in genomic perturbation screens: gold standards for human functional genomics.
    Hart T; Brown KR; Sircoulomb F; Rottapel R; Moffat J
    Mol Syst Biol; 2014 Jul; 10(7):733. PubMed ID: 24987113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular oncodiagnostics: where we are and where we need to go.
    Liu ET
    J Clin Oncol; 2003 Jun; 21(11):2052-5. PubMed ID: 12775728
    [No Abstract]   [Full Text] [Related]  

  • 4. The FDA approach to standardization and quality assurance of nucleic acid tests used to screen blood and plasma donations.
    Epstein JS; Hewlett IK
    Dev Biol (Basel); 2000; 102():223-7. PubMed ID: 10794110
    [No Abstract]   [Full Text] [Related]  

  • 5. Data sharing and evaluation.
    McPherson RA
    Cancer; 1992 Mar; 69(6 Suppl):1572-7. PubMed ID: 1540897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incentivizing standards development and adoption.
    Reddington F; Wilkinson JM; Clark R; Begent RH
    Nat Biotechnol; 2007 Apr; 25(4):391-2. PubMed ID: 17420740
    [No Abstract]   [Full Text] [Related]  

  • 7. HUMAN GENOME. The indispensable genome.
    Boone C; Andrews BJ
    Science; 2015 Nov; 350(6264):1028-9. PubMed ID: 26612934
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration.
    McFarland JM; Ho ZV; Kugener G; Dempster JM; Montgomery PG; Bryan JG; Krill-Burger JM; Green TM; Vazquez F; Boehm JS; Golub TR; Hahn WC; Root DE; Tsherniak A
    Nat Commun; 2018 Nov; 9(1):4610. PubMed ID: 30389920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Euclidean distance measurement and principal component analysis for gene identification.
    Ghosh A; Barman S
    Gene; 2016 Jun; 583(2):112-120. PubMed ID: 26877227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards future reference systems for GM analysis.
    Trapmann S; Corbisier P; Schimmel H; Emons H
    Anal Bioanal Chem; 2010 Mar; 396(6):1969-75. PubMed ID: 19960339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COLT-Cancer: functional genetic screening resource for essential genes in human cancer cell lines.
    Koh JL; Brown KR; Sayad A; Kasimer D; Ketela T; Moffat J
    Nucleic Acids Res; 2012 Jan; 40(Database issue):D957-63. PubMed ID: 22102578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network analysis of gene essentiality in functional genomics experiments.
    Jiang P; Wang H; Li W; Zang C; Li B; Wong YJ; Meyer C; Liu JS; Aster JC; Liu XS
    Genome Biol; 2015 Oct; 16():239. PubMed ID: 26518695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality assurance and proficiency testing in molecular oncology.
    Nakamura RM
    Cancer; 1992 Mar; 69(6 Suppl):1633-5. PubMed ID: 1540903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting.
    Iorio F; Behan FM; Gonçalves E; Bhosle SG; Chen E; Shepherd R; Beaver C; Ansari R; Pooley R; Wilkinson P; Harper S; Butler AP; Stronach EA; Saez-Rodriguez J; Yusa K; Garnett MJ
    BMC Genomics; 2018 Aug; 19(1):604. PubMed ID: 30103702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAGEL: a computational framework for identifying essential genes from pooled library screens.
    Hart T; Moffat J
    BMC Bioinformatics; 2016 Apr; 17():164. PubMed ID: 27083490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Searching for essential genes in cancer genomes].
    Pyatnitskiy MA; Karpov DS; Moshkovskii SA
    Biomed Khim; 2018 Aug; 64(4):303-314. PubMed ID: 30135277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fitness analyses of all possible point mutations for regions of genes in yeast.
    Hietpas R; Roscoe B; Jiang L; Bolon DN
    Nat Protoc; 2012 Jun; 7(7):1382-96. PubMed ID: 22722372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classifying microRNAs in cancer: the good, the bad and the ugly.
    Voorhoeve PM; Agami R
    Biochim Biophys Acta; 2007 Jun; 1775(2):274-82. PubMed ID: 17189674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human lymphoid cell lines GM9947 and GM9948 as intra- and interlaboratory reference standards for DNA typing.
    Frégeau CJ; Aubin RA; Elliott JC; Gill SS; Fourney RM
    Genomics; 1995 Jul; 28(2):184-97. PubMed ID: 8530025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assessment of genetic markers used for therapy stratification.
    Ambros IM; Benard J; Boavida M; Bown N; Caron H; Combaret V; Couturier J; Darnfors C; Delattre O; Freeman-Edward J; Gambini C; Gross N; Hattinger CM; Luegmayr A; Lunec J; Martinsson T; Mazzocco K; Navarro S; Noguera R; O'Neill S; Potschger U; Rumpler S; Speleman F; Tonini GP; Valent A; Van Roy N; Amann G; De Bernardi B; Kogner P; Ladenstein R; Michon J; Pearson AD; Ambros PF
    J Clin Oncol; 2003 Jun; 21(11):2077-84. PubMed ID: 12775732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.